Clinical Trial Update: A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation [NA]

View source ↗

Summary

This clinical trial compared HM3 and F2 lithotripters for stone fragmentation in urolithiasis. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urolithiasis

Snippet

Sponsor: Washington University School of Medicine | Conditions: Urolithiasis | NA | Status: TERMINATED